AFP, DCP, p53, PCNA, EZ2H, as well as other tissue markers proposed by some researchers, have a certain role in the diagnosis of HCC but are of limited use in suggesting the presence of precancerous lesions, especially in the differentiation of precancerous lesions from HCC. The gene discussed is PCNA; the disease is hepatocellular carcinoma.